You are here: Home » News-IANS » Health-Medicine
Business Standard

Vaccine for dust-mite allergies

IANS  |  New York 

If you are allergic to dust mites, here comes the help. Researchers have now developed a vaccine that can combat dust-mite allergies by switching on the body's immune response.

In animal tests, the nano-sized vaccine package lowered lung inflammation by 83 percent despite repeated exposure to the allergens.

"The vaccine package contains a booster that alters the body's inflammatory response to dust-mite allergens," informed paper's first author Vijaya Joshi, a graduate fellow in pharmacy at University of Iowa in US.

The vaccine takes advantage of the body's natural inclination to defend itself against foreign bodies.

A key to the formula lies in the use of an adjuvant - which boosts the potency of the vaccine - called CpG.

The CpG sets off a fire alarm within the body, springing immune cells into action. Those immune cells absorb the CpG and dispose of it.

"Combining the antigen (the vaccine) and CpG causes the body to change its immune response, producing antibodies that dampen the damaging health effects dust-mite allergens generally cause," explained Aliasger Salem, a professor in pharmaceutical sciences at University of Iowa.

In lab tests, the CpG-antigen package was absorbed 90 percent of the time by immune cells.

The researchers followed up those experiments by giving the package to mice and exposing the animals to dust-mite allergens every other day for nine days total.

In analyses conducted at the University's college of public health, packages with CpG yielded greater production of the desirable antibodies.

"This work suggests a way forward to alleviate mite-induced asthma in allergy sufferers," said Peter Thorne, a public health professor at the university.

The paper appeared in the journal American Association of Pharmaceutical Scientists.

Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Wed, July 23 2014. 13:16 IST
RECOMMENDED FOR YOU
RECOMMENDED FOR YOU